Peter Loftus
Wall Street Journal reporter - drugs, medical devices, healthcare. 215-881-7127, [email protected]
Last synced from Twitter 126d ago
Eli Lilly Earnings, Halted Covid-19 Drug Trial Disappoint Investors
Peter Loftus - WSJ 127d 1 tweets
The drugmaker reported lower-than-expected quarterly earnings due to pricing pressure on top products. It said it would proceed with plans to introduce a new coronavirus antibody treatment despite a recent setback.
Peter Loftus The drugmaker plans to continue pursuing authorization for its antibody drug as it tests its effectiveness in earlier-stage coronavirus illness via 127d
NIH Halts Study Exploring Treating Covid-19 With Lilly Antibody, Remdesivir
Peter Loftus - WSJ 128d 1 tweets
Federal health researchers have halted testing a combination of Eli Lilly’s Covid-19 antibody drug and remdesivir in hospitalized Covid-19 patients, after an independent committee found a lack of a benefit.
WSJ News Exclusive | Health Agency Scraps Coronavirus Ad Campaign, Leaving Santa Claus in the Cold
Stephanie Armour - WSJ 130d 43 tweets
A federal health agency halted a public-service coronavirus advertising campaign funded by $250 million in taxpayer money after it offered a special vaccine deal to an unusual set of essential workers: Santa Claus performers.
Peter Loftus HHS halts a taxpayer-funded advertising effort that aimed to ‘defeat despair, inspire hope’ on the pandemic by using Santa and celebrities like Dennis Quaid via 129d
To Find a Coronavirus Vaccine, GlaxoSmithKline Is Bonding With Its Biggest Competitors
Joseph Walker - WSJ 131d 2 tweets
The hunt for a solution to Covid-19 is producing an unlikely team of rivals in the cutthroat world of pharmaceuticals.
Peter Loftus GlaxoSmithKline and rival drug makers are bonding over a shared enemy: Covid-19. via 131d
WSJ News Exclusive | Covid-19 Vaccine Trial From AstraZeneca, Oxford Can Resume in U.S.
Tom Burton - WSJ 131d 4 tweets
Covid-19 vaccine trial From AstraZeneca PLC and the University of Oxford can resume in U.S., according to a person familiar with the matter.
Peter Loftus Covid-19 vaccine trial From AstraZeneca PLC and the University of Oxford can resume in U.S., according to a person familiar with the matter via 131d
Why Merck Is Playing Catch-Up in the Coronavirus Vaccine Chase
Gregory Zuckerman - WSJ 131d 2 tweets
Initial hesitation by senior executives about joining the global effort puts the company in an unusual spot: behind.
Peter Loftus As the coronavirus was spreading in February, some Merck executives and scientists were eager to ramp up work on a vaccine. They were overruled by more senior executives. via 131d
FDA Promises Strong Safety Standards for Covid-19 Vaccines as It Convenes Advisory Panel
Tom Burton - WSJ 132d 2 tweets
FDA officials gave fresh assurances that Covid-19 vaccines will undergo rigorous testing before being made widely available, during a meeting with outside medical experts aimed at bolstering the agency’s credibility.
Peter Loftus FDA promises strong vaccine safety standards as it convenes advisory panel via 132d
New U.S. Coronavirus Cases Surpass 60,000 for Second Day
Peter Loftus - WSJ 132d 1 tweets
The more than 62,000 new infections bring the total number reported in the U.S. to 8.34 million. More than 222,000 people have died in the country.
Pfizer Sets Up Its ‘Biggest Ever’ Vaccination Distribution Campaign
Costas Paris - WSJ 134d 5 tweets
The drugmaker is preparing to ship over a billion doses of Covid-19 vaccine using frozen boxes, cargo planes and trucks in a mega logistics operation.
Peter Loftus Pfizer is preparing to ship over a billion doses of Covid-19 vaccine using frozen boxes, cargo planes and trucks in a mega logistics operation via 132d
WSJ News Exclusive | Palantir to Help U.S. Track Covid-19 Vaccines
Peter Loftus, Rolfe Winkler - WSJ 133d 3 tweets
The data-mining company is developing a tool that health authorities plan to use to monitor the manufacture of coronavirus vaccines and determine where they should go.
WSJ News Exclusive | CDC Considers Shorter Covid-19 Quarantines for Children
Betsy McKay, Sarah Krouse - WSJ 133d 2 tweets
The CDC and state health departments are looking to minimize school disruptions for K-12 students who have been in close contact with people infected with Covid-19.
Covid-19 Vaccines to Be Stored Secretly Under Tight Security
WSJ 134d 6 tweets
Health authorities, hospitals and pharmaceutical companies plan to use fake shipments, GPS trackers and other steps to protect the shots against potential thefts.
Volunteers to Be Infected With Coronavirus in Planned Experimental Trials
jenny strasburg - WSJ 135d 2 tweets
U.K. researchers plan to start infecting healthy volunteers with tightly controlled doses of the coronavirus in what they called a first-of-its-kind effort to more rapidly gauge the effectiveness of multiple vaccines.
Peter Loftus Researchers plan to start infecting healthy volunteers with tightly controlled doses of the coronavirus in what they called a first-of-its-kind effort via 135d
Moderna CEO Expects Covid-19 Vaccine Interim Results in November
Peter Loftus - WSJ 135d 4 tweets
Moderna Chief Executive Stéphane Bancel said the federal government could authorize emergency use of the company’s experimental Covid-19 vaccine in December, if the company gets positive interim results in November from a large clinical trial.
Peter Loftus Moderna’s CEO says the best-case scenario for any FDA decision on the company’s vaccine would be December via 135d
WSJ News Exclusive | Some California Hospitals Refused Covid-19 Transfers for Financial Reasons, State Emails Show
Alexandra Berzon, Daniela Hernandez, Melanie Evans - WSJ 136d 3 tweets
Several large Southern California hospital systems improperly refused or delayed accepting Covid-19 patients based on their insurance status, according to internal emails among local and state government, hospital and emergency-response officials,...
Vertex Shares Plunge After Biotech Drops Closely Watched Drug Prospect
Joseph Walker - WSJ 139d 1 tweets
The flop of a promising drug from Vertex Pharmaceuticals led to a sharp drop in the company’s share price on Thursday as analysts questioned the biotech’s ability to replicate its success in cystic fibrosis and diversify its revenue.
Ahead of Covid-19 Vaccine, Half of Americans Indicate Reluctance, WSJ/NBC Poll Finds
Jared S. Hopkins - WSJ 140d 2 tweets
About 70% of registered voters surveyed said they would take a Covid-19 vaccine, although many want to wait until it has been available for a while to see if there are major problems or side effects, a new Wall Street Journal/NBC News poll shows.
Study of Eli Lilly Covid-19 Drug Paused Due to Safety Concern
Joseph Walker, Peter Loftus - WSJ 141d 2 tweets
A federally funded clinical trial testing an experimental Eli Lilly & Co. Covid-19 treatment has been paused due to a potential safety concern, the company said.
Peter Loftus A study exploring use of Eli Lilly's antibody drug in combination with remdesivir was halted via 141d
J&J Hopes Covid-19 Vaccine Trial Will Restart Shortly
Peter Loftus - WSJ 141d 2 tweets
Johnson & Johnson hopes to know within days whether it can resume testing its Covid-19 vaccine, although executives said they know little about the illness that prompted a pause in the clinical trials.
Peter Loftus Johnson & Johnson’s Covid-19 vaccine trial could resume soon, the firm said, but first outside researchers have to learn what made a volunteer ill via 141d
Johnson & Johnson Pauses Covid-19 Vaccine Trials Due to Sick Subject
Peter Loftus - WSJ 142d 3 tweets
The company says an independent committee is reviewing the subject’s illness, and it will review the medical information before deciding whether to restart the studies.